Nandu Thalange

Summary

Affiliation: Norfolk and Norwich University Hospital
Country: UK

Publications

  1. pmc Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2-16 Years
    Nandu Thalange
    Jenny Lind Children s Department, Norfolk and Norwich University Hospital, Norwich, UK
    Diabetes Ther 7:713-724. 2016
  2. pmc Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial
    N Thalange
    Jenny Lind Children s Department, Norfolk and Norwich University Hospital, Norwich, UK
    Diabet Med 30:216-25. 2013
  3. doi request reprint Treatment with insulin detemir or NPH insulin in children aged 2-5 yr with type 1 diabetes mellitus
    Nandu Thalange
    Jenny Lind Children s Department, Norfolk and Norwich University Hospital, Norwich, UK
    Pediatr Diabetes 12:632-41. 2011

Detail Information

Publications3

  1. pmc Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2-16 Years
    Nandu Thalange
    Jenny Lind Children s Department, Norfolk and Norwich University Hospital, Norwich, UK
    Diabetes Ther 7:713-724. 2016
    ..To study the long-term development (104 weeks) of insulin antibodies during treatment with insulin detemir (IDet) and insulin aspart (IAsp) in children with type 1 diabetes aged 2-16 years...
  2. pmc Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial
    N Thalange
    Jenny Lind Children s Department, Norfolk and Norwich University Hospital, Norwich, UK
    Diabet Med 30:216-25. 2013
    ..NPH (neutral protamine Hagedorn) insulin, in combination with insulin aspart, in subjects aged 2-16 years with Type 1 diabetes mellitus...
  3. doi request reprint Treatment with insulin detemir or NPH insulin in children aged 2-5 yr with type 1 diabetes mellitus
    Nandu Thalange
    Jenny Lind Children s Department, Norfolk and Norwich University Hospital, Norwich, UK
    Pediatr Diabetes 12:632-41. 2011
    ..In conclusion, long-term treatment with IDet in children aged 2-5 yr suggested similar glycaemic control, greater reduction in FPG, lower rates of hypoglycaemia, no inappropriate weight gain, and fewer adverse events compared with NPH...